We have previously shown that PPRHs are a valuable tool for gene silencing of relevant cancer targets such as dihydrofolate reductase, survivin, BCL2, TOP1, mTOR, MDM2, and MYC [3,16]. The gene discussed is TOP1; the disease is cancer.